$NVS 3 SEC Filings

Filed On	Filing
28 Oct 2025	Form 3: Novartis Ag, 10% owner · Tourmaline Bio, Inc. Holds 24,030,382 shares of Common Stock, par value $0.0001
27 Jun 2022	Form 3: Novartis Pharma Ag, 10% owner and 1 other · Precision Biosciences, Inc Holds 12,407,440 shares of Common Stock
14 Aug 2020	Form 3: Novartis Pharma Ag, 10% owner and 1 other · Cellular Biomedicine Group, Inc. Holds 1,458,257 shares of Common Stock
13 Jul 2020	Form 3: Novartis Pharma Ag, 10% owner and 1 other · Poseida Therapeutics, Inc.
25 Jun 2020	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Akouos, Inc.
18 Jun 2020	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Forma Therapeutics Holdings, Inc. Holds 331,221 shares of Common Stock
06 Nov 2019	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Galera Therapeutics, Inc.
22 May 2019	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Bicycle Therapeutics PLC
15 May 2018	Form 3: Novartis Ag, 10% owner · AveXis, Inc. Holds 36,816,476 shares of Common Stock, par value $0.0001
18 Apr 2018	Form 3: Novartis Institutes for BioMedical Research, Inc., 10% owner and 1 other · Surface Oncology, Inc.
27 Mar 2018	Form 3: Novartis Institutes for BioMedical Research, Inc., 10% owner and 1 other · Q32 Bio Inc.
23 Mar 2018	Form 3: Novartis Institutes for BioMedical Research, Inc., 10% owner and 1 other · Intellia Therapeutics, Inc. Holds 4,277,073 shares of Common Stock
28 Jun 2017	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Rein Therapeutics Inc
08 May 2017	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Altimmune, Inc. Holds 1,867,301 shares of Common Stock, par value $0.0001
17 Mar 2017	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Whitehawk Therapeutics Inc Holds 5,245,550 shares of Common Stock
25 Oct 2016	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Ra Pharmaceuticals, Inc.
05 May 2016	Form 3: Novartis Institutes for BioMedical Research, Inc., 10% owner and 1 other · Intellia Therapeutics, Inc.
06 Apr 2016	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Spyre Therapeutics Inc
10 Feb 2016	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · KINETA, INC./DE
16 Sep 2014	Form 3: Novartis Bioventures Ltd, 10% owner and 1 other · Eledon Pharmaceuticals Inc

Comments